Complement sera human
SIGMA/S1764 - lyophilized powder
Synonym: Human Serum Complement
MDL Number: MFCD00130855
Product Type: Chemical
| biological source | human |
| form | lyophilized powder |
| impurities | virus, tested |
| origin | USA origin |
| Quality Level | 200 ![]() |
| shipped in | dry ice |
| storage temp. | −20°C |
| technique(s) | cell culture | mammalian: suitable |
| Analysis Note: | Hemolytic titer (CH50 units per ml) is determined by method of Kabat and Mayer. Actual titer given on label. |
| Application: | Complement sera human has been used: • to incubate DLD-1 or SW-620 cells to quantify C5a release • in multiplex bead antibody-binding assay to assay C3d • in complement-dependent cytotoxicity assay |
| Application: | Complement sera human has been used: • to incubate DLD-1 or SW-620 cells to quantify C5a release • in multiplex bead antibody-binding assay to assay C3d • in complement-dependent cytotoxicity assay |
| Application: | The activity of complement sera can be determined by hemolytic assays in vitro. |
| Disclaimer: | RESEARCH USE ONLY. This product is regulated in France when intended to be used for scientific purposes, including for import and export activities (Article L 1211-1 paragraph 2 of the Public Health Code). The purchaser (i.e. enduser) is required to obtain an import authorization from the France Ministry of Research referred in the Article L1245-5-1 II. of Public Health Code. By ordering this product, you are confirming that you have obtained the proper import authorization. |
| General description: | Complement serum is prepared from pooled human plasma and lyophilized from the amount of serum indicated on the label. |
| Physical form: | Lyophilized powder from indicated amount of serum |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Storage Temp. | −20°C |
| UNSPSC | 12352202 |

